209 related articles for article (PubMed ID: 8931812)
1. Safety of fosphenytoin sodium.
Fierro LS; Savulich DH; Benezra DA
Am J Health Syst Pharm; 1996 Nov; 53(22):2707-12. PubMed ID: 8931812
[TBL] [Abstract][Full Text] [Related]
2. Fosphenytoin (Cerebyx).
Browne TR
Clin Neuropharmacol; 1997 Feb; 20(1):1-12. PubMed ID: 9037568
[TBL] [Abstract][Full Text] [Related]
3. Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures.
Fischer JH; Patel TV; Fischer PA
Clin Pharmacokinet; 2003; 42(1):33-58. PubMed ID: 12489978
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology and pharmacokinetics of fosphenytoin.
Browne TR; Kugler AR; Eldon MA
Neurology; 1996 Jun; 46(6 Suppl 1):S3-7. PubMed ID: 8649612
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and clinical effects of phenytoin and fosphenytoin in children with severe malaria and status epilepticus.
Ogutu BR; Newton CR; Muchohi SN; Otieno GO; Edwards G; Watkins WM; Kokwaro GO
Br J Clin Pharmacol; 2003 Jul; 56(1):112-9. PubMed ID: 12848783
[TBL] [Abstract][Full Text] [Related]
6. The safety, tolerability, and pharmacokinetics of fosphenytoin after intramuscular and intravenous administration in neurosurgery patients.
Boucher BA; Feler CA; Dean JC; Michie DD; Tipton BK; Smith KR; Kramer RE; Young B; Parks BR; Kugler AR
Pharmacotherapy; 1996; 16(4):638-45. PubMed ID: 8840370
[TBL] [Abstract][Full Text] [Related]
7. Clinical experience with fosphenytoin in adults: pharmacokinetics, safety, and efficacy.
Knapp LE; Kugler AR
J Child Neurol; 1998 Oct; 13 Suppl 1():S15-8; discussion S30-2. PubMed ID: 9796747
[TBL] [Abstract][Full Text] [Related]
8. Fosphenytoin: a novel phenytoin prodrug.
Boucher BA
Pharmacotherapy; 1996; 16(5):777-91. PubMed ID: 8888074
[TBL] [Abstract][Full Text] [Related]
9. Intramuscular use of fosphenytoin: an overview.
Uthman BM; Wilder BJ; Ramsay RE
Neurology; 1996 Jun; 46(6 Suppl 1):S24-8. PubMed ID: 8649611
[TBL] [Abstract][Full Text] [Related]
10. Fosphenytoin.
Eriksson K; Keränen T; Kälviäinen R
Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):695-701. PubMed ID: 19473113
[TBL] [Abstract][Full Text] [Related]
11. Bioavailability of intravenous fosphenytoin sodium in healthy Japanese volunteers.
Inoue Y; Usui N; Hiroki T; Shimizu K; Kobayashi S; Shimasaki S
Eur J Drug Metab Pharmacokinet; 2013 Jun; 38(2):139-48. PubMed ID: 22968854
[TBL] [Abstract][Full Text] [Related]
12. Fosphenytoin.
Luer MS
Neurol Res; 1998 Mar; 20(2):178-82. PubMed ID: 9522355
[TBL] [Abstract][Full Text] [Related]
13. Intravenous administration of fosphenytoin: options for the management of seizures.
Ramsay RE; DeToledo J
Neurology; 1996 Jun; 46(6 Suppl 1):S17-9. PubMed ID: 8649609
[TBL] [Abstract][Full Text] [Related]
14. Anticonvulsant effect of fosphenytoin in amygdala-kindled rats: comparison with phenytoin.
Löscher W; Reissmüller E; Ebert U
Epilepsy Res; 1998 Mar; 30(1):69-76. PubMed ID: 9551846
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of phenytoin following intravenous and intramuscular administration of fosphenytoin and phenytoin sodium in the rabbit.
Muchohi SN; Kokwaro GO; Maitho TE; Munenge RW; Watkins WM; Edwards G
Eur J Drug Metab Pharmacokinet; 2002; 27(2):83-9. PubMed ID: 12064376
[TBL] [Abstract][Full Text] [Related]
16. Safety and tolerance of multiple doses of intramuscular fosphenytoin substituted for oral phenytoin in epilepsy or neurosurgery.
Wilder BJ; Campbell K; Ramsay RE; Garnett WR; Pellock JM; Henkin SA; Kugler AR
Arch Neurol; 1996 Aug; 53(8):764-8. PubMed ID: 8759983
[TBL] [Abstract][Full Text] [Related]
17. Safety, Tolerability, and Pharmacokinetics of Fosphenytoin Loading in Patients With Subarachnoid Hemorrhage.
Kim DW; Kim TE; Ji M; Chun YI
Clin Neuropharmacol; 2015; 38(6):248-51. PubMed ID: 26536021
[TBL] [Abstract][Full Text] [Related]
18. The safety and efficacy of fosphenytoin for the treatment of status epilepticus.
Popławska M; Borowicz KK; Czuczwar SJ
Expert Rev Neurother; 2015; 15(9):983-92. PubMed ID: 26289487
[TBL] [Abstract][Full Text] [Related]
19. New anticonvulsant drugs. Focus on flunarizine, fosphenytoin, midazolam and stiripentol.
Bebin M; Bleck TP
Drugs; 1994 Aug; 48(2):153-71. PubMed ID: 7527321
[TBL] [Abstract][Full Text] [Related]
20. Fosphenytoin use in children.
Pellock JM
Neurology; 1996 Jun; 46(6 Suppl 1):S14-6. PubMed ID: 8649608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
